Is Briacell Therapeutics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Briacell Therapeutics Corp (BCT.TO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Briacell Therapeutics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Briacell Therapeutics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Briacell Therapeutics Corp?

Muslim investors may consider investing in Briacell Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Briacell Therapeutics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Briacell Therapeutics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Briacell Therapeutics Corp updated?

The Shariah compliance status of Briacell Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Briacell Therapeutics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Briacell Therapeutics Corp?

You can check the latest Shariah compliance status of Briacell Therapeutics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BCT.TO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 12, 2026

Report Source: 2026 2nd Quarter Report

Analyst's Ratings for Briacell Therapeutics Corp (BCT.TO)

Based on 5 analysts giving stock ratings to Briacell Therapeutics Corp in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Briacell Therapeutics Corp. Stock Analysis BCT.TO

Canada Health Care Nano Cap Report: Q2, 2026

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The firm is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. The company is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

Key Statistics of Briacell Therapeutics Corp (BCT.TO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD4.13CAD5.60

Today's Open

CAD5.60

Volume

131.58K

P/E Ratio (TTM)

52 Week Range

CAD4.13CAD51.50

Market Cap

40.17M

Avg. Volume

20.61K

Dividend Yield

Financial Metrics & Statements of Briacell Therapeutics Corp (BCT.TO)

FAQ's for Briacell Therapeutics Corp (BCT.TO)

According to Musaffa’s Shariah screening methodology, Briacell Therapeutics Corp (BCT.TO) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.